Dear Editor, The American Heart Association (AHA) and American College of Cardiology (ACC) have released their 2013 Guidelines on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults.
Monthly Archives: December 2013
Dentist challenged Committee’s jurisdiction
Ed Madden, BL, looks at a recent UK High Court case in which a dentist challenged the jurisdiction of a General Dental Council disciplinary committee to consider fraud charges against him.
Colobreathe
Company: Forest Laboratories UK Ltd.
Dexketoprofen Rowex
Company: Rowex Ltd.
Ultibro Breezhaler
Company: Novartis Ireland Ltd.
Zyclara
Company: Meda Health Sales.
New Indication for Eylea
Bayer Healthcare wishes to announce that Eylea (aflibercept) Injection has been approved by the European Commission for the treatment of visual impairment due to macular oedema secondary to Central Retinal Vein Occlusion (CRVO).
Starlix – Notice of Discontinuation
Novartis Ireland would like to advise you that Starlix, an oral antidiabetic agent used in the management of Type 2 diabetes mellitus, has been discontinued for the Irish market.